Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00036556
Other study ID # M00-244
Secondary ID
Status Completed
Phase Phase 3
First received May 10, 2002
Last updated August 13, 2007
Start date June 2001

Study information

Verified date August 2007
Source Abbott
Contact n/a
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Interventional

Clinical Trial Summary

This study is being done to evaluate the safety and efficacy of atrasentan in men with non-metastatic hormone-refractory prostate cancer.


Other known NCT identifiers
  • NCT00026455

Recruitment information / eligibility

Status Completed
Enrollment 941
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Male
Age group 19 Years and older
Eligibility Inclusion Criteria:

- Have been diagnosed with prostate cancer.

- Have a rising PSA while on hormone therapy or following surgical castration.

Exclusion Criteria:

- Have evidence of distant metastatic disease on screening bone scan or CT scan.

- Have received cytotoxic chemotherapy.

- Have received opioid or narcotic medications (such as codeine or morphine) or radiation for pain caused by your prostate cancer in the last 6 months.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Atrasentan


Locations

Country Name City State
Australia Repatriation General Hospital Daws Park South Australia
Australia Peter Maccallum Cancer Institute East Melbourne Victoria
Australia Royal Brisbane Hospital Herston Queensland
Australia Bayside Urology Mentone Victoria
Australia Royal Melbourne Hospital Parkville Victoria
Australia Prince Of Wales Hospital Randwick New South Wales
Australia Westmead Public Hospital Westmead New South Wales
Australia Princess Alexandra Hospital Woolloongabba
Austria A. Ö. Krankenhaus Mistelbach Mistelbach
Austria Klinik fur Urologie der Universitat Wien Wien
Belgium A.Z. Middelheim Antwerpen
Belgium A Z St Jan Brugge
Belgium University Hospital Erasme Bruxelles
Belgium Uz Gent Gent
Belgium Private Practice Dr.Vekemans Hasselt
Belgium C.H.U. Liege Liege
Belgium St-Elisabeth Ziekenhuis Turnhout
Canada The Male Health Centres Barrie Ontario
Canada The Urology Resource Centre Burlington Ontario
Canada Tom Baker Cancer Center Calgary, Alberta
Canada Cross Cancer Institute Edmonton, Alberta
Canada Service Radio-Oncologie, Chus Fleurimont, Quebec
Canada Professional Corporation Fredericton New Brunswick
Canada Queen Elizabeth II Health Sciences Center Halifax Nova Scotia
Canada Hamilton & District Urology Association Hamilton, Ontario
Canada Wilson Urology Kelowna British Columbia
Canada Valley Professional Centre Kentville Nova Scotia
Canada Kingston General Hospital Kingston Ontario
Canada Probidity Medical Research Kitchener Ontario
Canada London Health Sciences Centre London Ontario
Canada Quest Clinical Trials Markham Ontario
Canada Hopital Notre-Dame Montreal Quebec
Canada Royal Victoria Hospital Montreal Quebec
Canada Walk-In Clinic North Bay Ontario
Canada Jack Barkin, M.D. North York Ontario
Canada The Male Health Centres Oakville Ontario
Canada Ottawa Hospital Civic Campus Ottawa Ontario
Canada Ultramed Pointe Claire Quebec
Canada Chuq Pavillon Hotel-Dieu Quebec
Canada Peter Lau, MD Saskatoon, Saskatchewan
Canada Advanced Male Fertility Clinic Scarborough, Ontario
Canada Northeastern Ontario Regional Cancer Centre Sudbury, Ontario
Canada Dr. Cal Andreou Surrey British Columbia
Canada Princess Margaret Hospital Toronto Ontario
Canada Sunnybrook Health Sciences Centre Toronto Ontario
Canada Vancouver Hospital & Health Sciences Centre Vancouver British Columbia
Canada Dr. Gary Steinhoff, Clinical Research Victoria British Columbia
Canada Dr. P. J. Pommerville, Inc. Victoria British Columbia
Canada Abbott Clinic Winnipeg Manitoba
France Hôpital D´Auxerre Auxerre
France Hôpital Henri Mondor Creteil
France Hopital Intercommunal Creteil Cedex
France Hôpital Salvator Marseille Cedex
France Hôpital Pasteur Nice Cedex
France Hopital Bichat Claude Bernard Paris
France Hôpital Cochin Paris Cedex 14
France Hôpital Saint Louis Paris Cedex
France Centre Hospitalier Rene Dubos Pontoise Cedex
France Hopital De Pontchaillou Rennes Cedex
France Hopital De Rangueil Toulouse Cedex
Germany Allgemeines Krankenhaus Urologie Celle
Germany Universitätsklinikum Urologie Essen
Germany Universitätsklinkum Freiburg
Germany Allgemeines Krankenhaus Barmbek Hamburg
Germany Universitätsklinikum Hamburg-Eppendorf Hamburg
Germany Klinik Und Poliklinik für Urologie und Kinder Homburg / Saar
Germany Universitätsklinikum Lübeck Urologie Lübeck
Germany Universitätsklinikum Mannheim Mannheim
Germany Klinikum Rechts Der Isar Munchen
Germany Urologische Klinik Und Poliklinik Grosshadern Munchen
Germany Universitat Ulm ULM
Germany Klinikum Wuppertal GmbH Wuppertal
Greece 'Alexandra' Hospital Athens
Greece Pe.Pa.G.N.I Hospital Heraklion
Greece G. Genimatas Hospital Thessaloniki
Ireland Mater Misericordiae Hospital Dublin
Ireland St Vincent'S Hospital Dublin
Ireland Tallaght Hospital Dublin
Italy Clinica Urologica I - Università di Bari Bari
Italy Istituto Nazionale per la Ricerca sul Cancro -IST Genoa
Italy Clinica Urologica - Università Di Milano Milan
Italy Istituto Europeo di Oncologia Milan
Italy Istituto di Urologia Padova
Italy Policlinico G. B. Rossi Verona
Netherlands Amc Amsterdam
Netherlands Rijnstate Hospital Arnhem
Netherlands Medisch Spectrun Twente Enschede
Netherlands Atrium Heerlen Heerlen
Netherlands St Franciscus Gasthuis Rotterdam
Netherlands University Hospital Rotterdam Rotterdam
New Zealand Canterbury Urology Research Trust Christchurch
New Zealand Promed Urology Ltd. Tauranga
Poland Samodzielny Publiczny ZOZ Bydgoszcz
Poland Katedra i Klinika Urologii - Akademia Medyczna w Gdansku Gdansk
Poland Specjalistyczny Szpital Urologiczny Katowice
Poland Instytut im. Marii Sklodowskiej-Curie Warszawa
Poland Szpital Kliniczny Dzieciatka Jezus Warszawa
Poland Akademia Medyczna we Wroclawiu Wroclaw
South Africa University Of Stellenbosch Cape Town
South Africa University Of Natal - Nelson R Mandela School of Medicine Durban
South Africa Kenridge St Joseph Wingl Parktown
South Africa Mediclinic Hospital Petermaritzburg 3201
South Africa Medi-Clinic Hospital Pietermaritzburg
South Africa Medical Centre Pietermaritzburg
South Africa Pretoria Urology Hospital Pretoria
Spain Hospital de la Ribera Alcira (Valencia)
Spain Hospital Vall D'Hebron Barcelona
Spain Hospital de Galdakao Galdakao-Vizcaya
Spain Hospital Juan Canalejo La Coruna
Spain Clinica Puerta De Hierro Madrid
Spain Hospital 12 De Octubre Madrid
Spain Hospital Carlos Haya Malaga
Spain Hospital Marques De Valdecilla Santander
Spain Instituto Valenciano De Oncologia Valencia
Sweden Sahlgrenska University Hospital Gothenburg
Sweden Linkoping University Hospital Linkoping
Sweden Lund University Hospital Lund
Sweden Malmo University Hospital MAS Malmo
Sweden Karolinska Hospital Stockholm
Sweden Uppsala University Hospital Uppsala
United Kingdom Clatterbridge Centre For Oncology Bebington Wirral
United Kingdom St Lukes Hospital Bradford West Yorkshire
United Kingdom Southmead Hospital Bristol
United Kingdom Addenbrookes Hospital Cambridge
United Kingdom St Richard'S Hospital Chichester
United Kingdom Leighton Hospital Crewe
United Kingdom Western General Hospital Edinburgh, Scotland
United Kingdom Royal Devon And Exeter Hospital Exeter, Devon
United Kingdom Gartnavel General Hospital Glasgow
United Kingdom Glasgow Royal Infirmary Glasgow
United Kingdom Northwick Park Hospital Harrow Middlesex
United Kingdom Clinical Research Centre - St Georges Hospital London
United Kingdom Royal Free Hospital London
United Kingdom St Batholomew'S Hospital London
United Kingdom Hope Hospital Salford
United Kingdom Royal Hallamshire Hospital Sheffield
United Kingdom Southampton General Southampton
United Kingdom Lister Hospital Stevenage Hertfordshire
United Kingdom The Institute Of Cancer Research - Royal Marsden Hospital Sutton Surrey
United Kingdom Taunton And Somerset Hospital Taunton Somerset
United States Albany Medical Center South Clinical Campus Albany New York
United States UNM Medical Center Albuquerque New Mexico
United States Urologic Associates of Allentown Allentown Pennsylvania
United States Alaska Clinical Research Center, LLC Anchorage Alaska
United States Emory Clinic Atlanta Georgia
United States Peachtree Hematology/Oncology Consultants Atlanta Georgia
United States Sandy Springs Urology Atlanta Georgia
United States Dreyer Medical Clinic Aurora Illinois
United States South Fl Medical Research Aventura Florida
United States Johns Hopkins Oncology Center Baltimore Maryland
United States Billings Oncology Associates Billings, Montana
United States Massachusetts General Hospital Boston Massachusetts
United States HemOnCare, PC Brooklyn New York
United States University Of Vermont Burlington, Vermont
United States The University Of North Carolina At Chapel Hill Chapel Hill North Carolina
United States Blumenthal Cancer Center Charlotte North Carolina
United States Mckay Urology Charlotte, North Carolina
United States Urology Specialists Of The Carolinas Charlotte, North Carolina
United States Wyoming Research Foundation Cheyenne Wyoming
United States Christopher Ryan, MD Chicago Illinois
United States Northwestern University Medical School Chicago Illinois
United States Progressive Care, S.C. Chicago Illinois
United States Weiss Memorial Hospital Chicago, Illinois
United States Robin V. Smith, MD Chula Vista California
United States University Of Cincinnati Medical Center Cincinnati, Ohio
United States Dept of Veteran's Affairs North Texas Healthcare System Dallas Texas
United States Ntouch Research Corporation Dallas Texas
United States The University Of TX SW Medical Center At Dallas Dallas Texas
United States Urologic Associates, Pc Davenport Iowa
United States Atlanta Va Medical Center Decatur Georgia
United States Urology Associate, Pc Denver, Colorado
United States Iowa Urology Des Moines Iowa
United States Oregon Urology Specialists Eugene Oregon
United States Evanston Hospital Kellogg Cancer Center Evanston Illinois
United States Welborn Clinic Evansville Indiana
United States Welborn Clinic -East Evansville Indiana
United States Clinical Physiology Associates Fort Myers Florida
United States Urology Associate Of Central California Fresno, California
United States South Valley Medical Plaza Gilroy California
United States Michigan Medical Urology Grand Rapids Michigan
United States Drs. Werner, Murdock, & Francis, Pa Urology Assoc. Greenbelt Maryland
United States The Urology Center Greensboro, North Carolina
United States The Medical Oncology Group Gulfport, Mississippi
United States Milton S. Hershey Medical Center Hershey Pennsylvania
United States Urology Centers Of Alabama Homewood, Alabama
United States Mississippi Center For Clinical Research, LLC Jackson Mississippi
United States Kansas University Medical Center Kansas City, Kansas
United States San Diego Urology Center La Mesa California
United States South Orange County Medical Research Center Laguna Hills California
United States Urological Associates Of Lancaster Lancaster Pennsylvania
United States Arkansas Urologial Associates, PA Little Rock Arkansas
United States UCLA School of Medicine Los Angeles California
United States University of TN - Memphis Memphis Tennessee
United States Medical College of Wisconsin Milwaukee Wisconsin
United States Midwest Research Specialists, LLC Milwaukee Wisconsin
United States Urology Associates Nashville Tennessee
United States Vanderbilt University Medical Center Nashville, Tennessee
United States Advanced Research Institute New Port Richey Florida
United States Beth Israel Medical Center New York New York
United States NYU Medical Center New York New York
United States Nyack Hospital Nyack New York
United States University of Nebraska Medical Center Omaha, Nebraska
United States VA Palo Alto Palo Alto California
United States Albert Einstein Medical Center Philadelphia Pennsylvania
United States University Of Pittsburgh Pittsburgh Pennsylvania
United States Multimed Research Providence, Rhode Island
United States Nevada Urology Associate Reno Nevada
United States Virginia Urology Center Richmond, Virginia
United States Mayo Clinic Rochester Minnesota
United States Mid Atlantic Clinical Research Rockville Maryland
United States Western Urological Clinic Salt Lake City Utah
United States Anthony Middleton, M.D. Salt Lake City, Utah
United States Uthscsa San Antonio Texas
United States Hillcrest Urological Medical Group, Inc. San Diego California
United States Urology Associates Of San Luis Obispo San Luis Obispo, California
United States Pacific Clinical Research Santa Monica California
United States Dattoli Cancer Center Sarasota, Florida
United States Urology Treatment Center Sarasota, Florida
United States Seattle Urological Associates Seattle Washington
United States University Of Washington School Of Medicine Seattle Washington
United States Jeffrey Frankel, M.D. Seattle, Washington
United States LSUHSC Shreveport Louisiana
United States Regional Urology Shreveport Louisiana
United States Michigan Institute Of Urology, Pc St. Clair Shores Michigan
United States Lakeside Urology, PC St. Joseph Michigan
United States St. Joseph Oncology St. Joseph Missouri
United States Washington University St. Louis Missouri
United States Madigan Army Medical Center Tacoma, Washington
United States Southeastern Urological Center, P.A. Tallahassee Florida
United States Scott & White Memorial Hospital Temple, Texas
United States Western Clinical Research, Inc. Torrance, California
United States Advanced Clinical Trials Tucson Arizona
United States Urologic Specialists Of Oklahoma, Inc. Tulsa, Oklahoma
United States Center for Urologic Care West Reading, Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Abbott

Countries where clinical trial is conducted

United States,  Australia,  Austria,  Belgium,  Canada,  France,  Germany,  Greece,  Ireland,  Italy,  Netherlands,  New Zealand,  Poland,  South Africa,  Spain,  Sweden,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time-to-disease progression will be determined by the time to onset of the earliest of one of the following events: New skeletal lesions, new metastatic extra-skeletal lesions, or an event due to metastatic prostate cancer. Every 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04964271 - Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants
Completed NCT02546908 - A Registry of Participants With Prostate Cancer in Asia
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT01683994 - Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer Phase 1/Phase 2
Completed NCT04838613 - Study of Diagnostic Performance of [18F]CTT1057 in BCR Phase 3
Completed NCT02364531 - A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting
Completed NCT01929655 - Japanese BAY88-8223 Monotherapy Phase II Study Phase 2
Active, not recruiting NCT05022849 - A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants Phase 1
Completed NCT03261999 - Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer Phase 3
Terminated NCT04907227 - Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension Phase 3
Active, not recruiting NCT03587285 - A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer Phase 1/Phase 2
Completed NCT02217566 - Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy Phase 2
Not yet recruiting NCT04101305 - Measurement of Circulating Tumor Cells in Prostate Cancer
Active, not recruiting NCT02950064 - A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations Phase 1
Terminated NCT03066154 - Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer Phase 1
Withdrawn NCT02905201 - A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) N/A
Completed NCT02692976 - Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer Patients Phase 2
Terminated NCT01420965 - Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer Phase 2
Completed NCT01441713 - Treatment Frequency and Satisfaction in Patients With Advanced Prostate Cancer N/A